Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 30, 2019

SELL
$1.25 - $5.0 $223,213 - $892,855
-178,571 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$4.84 - $9.07 $864,283 - $1.62 Million
178,571 New
178,571 $1.25 Million
Q3 2018

Nov 13, 2018

SELL
$13.02 - $17.54 $651,000 - $877,000
-50,000 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$16.51 - $19.85 $825,500 - $992,500
50,000 New
50,000 $826,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $798M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Granite Point Capital Management, L.P. Portfolio

Follow Granite Point Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Granite Point Capital Management, L.P. with notifications on news.